Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • MIDDLEBROOK PHARMACEUTICAL I Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 74.98 M 1.95 M 15.38 M 29.85 M 30.05 M
    Net Receivables 426,138.00 687,787.00 975,664.00 878,264.00 206,001.00
    Total Inventories 334,739.00 687,933.00 2.08 M 219,451.00 179,738.00
    Progress Payments & Others -38,920.00 -1.00 M -293,956.00 -154,367.00 0.00
    Prepaid Expenses 824,501.00 1.14 M 1.01 M 172,000.00
    Other Current Assets 1.60 M 0.00 0.00 797,253.00 1.04 M
    Current Assets Total 78.16 M 4.47 M 19.44 M 31.74 M 31.48 M
    Long Term Receivables 0.00 0.00 0.00 0.00 121,500.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 1.40 M 872,180.00 872,180.00 2.07 M 2.18 M
    Property, Plant & Equipment Net 4.19 M 10.93 M 11.76 M 14.45 M 16.52 M
    Property, Plant & Equipment Gross 14.24 M 23.19 M 20.86 M 20.87 M 20.12 M
    Accumulated Depreciation 10.05 M 12.26 M 9.10 M 6.42 M 3.60 M
    Other Assets 11.45 M 7.39 M 9.93 M 9.54 M 10.69 M
    Deferred Charges 0.00 0.00 207,024.00 175,879.00 226,123.00
    Tangible Other Assets 0.00 174,965.00 1.34 M 0.00 0.00
    Intangible Other Assets 11.45 M 7.22 M 8.38 M 9.36 M 10.69 M
    Total Assets 95.19 M 23.67 M 42.01 M 57.80 M 61.00 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 0.00 6.96 M 895,204.00 1.01 M
    Accrued Payroll 783,698.00 1.45 M 1.31 M 1.03 M 1.36 M
    Income Taxes Payable
    Dividends Payable
    Other Current Liabilities 5.36 M 4.17 M 6.70 M 6.04 M 5.35 M
    Current Liabilities Total 9.13 M 7.27 M 17.26 M 9.65 M 11.61 M
    Long Term Debt 0.00 0.00 0.00 672,208.00 1.57 M
    Provision for Risks & Charges
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 11.62 M 12.80 M 12.88 M 12.89 M 8.08 M
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 2.50 M 2.10 M 0.00 1.24 M 0.00
    Total Liabilities 23.26 M 22.18 M 30.13 M 24.45 M 21.26 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 7.34 M 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 71.93 M -5.85 M 11.87 M 33.34 M 39.74 M
    Common Stock 864,332.00 467,488.00 363,625.00 297,652.00 227,067.00
    Capital Surplus 307.70 M 189.02 M 164.59 M 144.77 M 120.32 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves 275,951.00 -623,051.00 -2.61 M -6.13 M
    Unappropriated (Free) Reserves 0.00 0.00 0.00
    Retained Earnings -236.91 M -195.33 M -153.09 M -111.10 M -78.11 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities 0.00 0.00 -73.00 -3,495.00 -90,659.00
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 95.19 M 23.67 M 42.01 M 57.80 M 61.14 M
    Common Shares Outstanding 86.43 M 46.75 M 36.36 M 29.77 M 22.71 M